Cyclo(-RGDyK) – Immunology – Antigens/Epitotes/Pools/Librairies

The cyclic pentapeptide cyclo(-Arg-Gly-Asp-d-Phe-Lys-) is a highly potent and selective inhibitor for the alphavβ3 integrin receptor. A related compound, cyclo(-Arg-Gly-Asp-d-Phe-Val), is a promising anti-cancer drug candidate- it inhibits angiogenesis and induces apoptosis in vascular cells. Cyclic RGD-containing peptides are selective antagonists of integrins, proteins that play important roles in cell-cell and cell-matrix interactions. In a suitably labelled form, these peptides may serve as useful tools for diagnostic imaging and peptide targeted therapy of some types of cancer.

 

Technical specification

 KD20 peptide Sequence : [LacN(0,5)]RGD(dY)K
 KD20 peptide MW : 619.3 g/mol
 KD20 peptide Purity : > 95%
 KD20 peptide Counter-Ion : TFA Salts
Peptide library synthesis KD20 peptide Delivery format : Lyophilized

Price

 

Product Size Price €
Price $
CRB1001169-0.5 mg 0.5 mg 282 € 226 $
CRB1001169-1 mg 1 mg 385 € 308 $
CRB1001169-
CRB1001169-
CRB1001169-

For Bulk Orders